These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15366332)

  • 1. Efficacy of Lantigen B in the prevention of bacterial respiratory infections.
    Pozzi E; Serra C
    Monaldi Arch Chest Dis; 2004; 61(1):19-27. PubMed ID: 15366332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of recurrent respiratory tract infections: a literature review of the activity of the bacterial lysate Lantigen B.
    Braido F; Melioli G; Nicolini G; Canonica GW
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7756-7767. PubMed ID: 37667954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of sublingual polyvalent bacterial vaccine (Lantigen B) in children with recurrent respiratory infection: a randomized double-blind controlled clinical trial].
    Chen AH; Chen RC; Zhang CQ; Chen D; Huang S; Lin Y; Zhan J; Zhong N
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):463-4. PubMed ID: 15265442
    [No Abstract]   [Full Text] [Related]  

  • 6. The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.
    Braido F; Melioli G; Candoli P; Cavalot A; Di Gioacchino M; Ferrero V; Incorvaia C; Mereu C; Ridolo E; Rolla G; Rossi O; Savi E; Tubino L; Reggiardo G; Baiardini I; di Marco E; Rinaldi G; Canonica GW; ; Accorsi C; Bossilino C; Bonzano L; DiLizia M; Fedrighini B; Garelli V; Gerace V; Maniscalco S; Massaro I; Messi A; Milanese M; Peveri S; Penno A; Pizzimenti S; Pozzo T; Raie A; Regina S; Sclifò F
    Immunol Lett; 2014 Dec; 162(2 Pt B):185-93. PubMed ID: 25445613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients.
    Jareoncharsri P; Bunnag C; Tunsuriyawong P; Assanasane P; Voraprayoon S; Pinkaew B
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):223-30. PubMed ID: 15198340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
    Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M; Eckenberger HP
    Fortschr Med; 1992 Nov; 110(30):565-70. PubMed ID: 1468743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial lysates in the prevention of respiratory tract infections.
    Jurkiewicz D; Zielnik-Jurkiewicz B
    Otolaryngol Pol; 2018 Oct; 72(5):1-8. PubMed ID: 30460909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational study on the performance of the Narhinel method (nasal aspirator and physiological saline solution) versus physiological saline solution in the prevention of recurrences of viral rhinitis and associated complications of the upper respiratory tract infections (URTI), with a special focus on acute rhinosinusitis and acute otitis of the middle ear.
    Montanari G; Ceschin F; Masotti S; Bravi F; Chinea B; Quartarone G
    Minerva Pediatr; 2010 Feb; 62(1):9-16, 17-21. PubMed ID: 20212394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P; Brachmann I; Werchan D; Wittig C; Tischner H
    Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S; Tazza R
    Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicentric study of the effectiveness of ribosomal vaccine (D 53) in the prevention of episodes of bacterial infection encountered in ENT pathology.
    Charachon R; Lavillauroy PJ; Fumex JP
    Arzneimittelforschung; 1980; 30(1a):214-20. PubMed ID: 6892781
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of respiratory infections.
    Marcy SM
    Pediatr Infect Dis; 1985; 4(4):442-6. PubMed ID: 3895184
    [No Abstract]   [Full Text] [Related]  

  • 17. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A; Vecchia LD
    Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection.
    Esposito S; Marchisio P; Prada E; Daleno C; Porretti L; Carsetti R; Bosco A; Ierardi V; Scala A; Principi N
    Vaccine; 2014 May; 32(22):2546-52. PubMed ID: 24681270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections].
    Shmeleva EA; Vartanian RV; Aleshkin VA; Paramonova IuA; Baturina iG; Malyshev NA
    Vestn Ross Akad Med Nauk; 2008; (3):12-6. PubMed ID: 18421903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccinations in recurrent urinary tract infections--an observation study relating to health economy].
    Lenk VS; Dorsch B
    Aktuelle Urol; 2009 Nov; 40(6):360-5. PubMed ID: 19899016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.